Vera Therapeutics (VERA)
NASDAQ:VERA
US Market
Holding VERA?
Track your performance easily

Vera Therapeutics (VERA) Financial Statements

227 Followers

Vera Therapeutics Financial Overview

Vera Therapeutics's market cap is currently ―. The company's EPS TTM is $-2.042; its P/E ratio is -17.93; Vera Therapeutics is scheduled to report earnings on August 8, 2024, and the estimated EPS forecast is $-0.56. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 482.00K$ 482.00K$ 482.00K$ 482.00K$ 482.00K
Gross Profit$ 482.00K$ 482.00K$ 482.00K$ 482.00K$ 482.00K
EBIT$ -26.90M$ -24.75M$ -19.09M$ -19.39M$ -28.98M
EBITDA$ -26.38M$ -24.22M-$ -18.82M$ -28.40M
Net Income Common Stockholders$ -28.38M$ -25.80M$ -20.04M$ -20.16M$ -29.85M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 403.66M$ 160.72M$ 159.94M$ 181.02M$ 197.15M
Total Assets$ 419.36M$ 175.55M$ 175.62M$ 195.18M$ 209.56M
Total Debt$ 53.26M$ 53.71M$ 29.52M$ 30.09M$ 30.68M
Net Debt$ -350.40M$ -107.01M$ -130.42M$ -150.93M$ -166.47M
Total Liabilities$ 65.81M$ 73.86M$ 51.91M$ 54.66M$ 51.90M
Stockholders Equity$ 353.54M$ 101.69M$ 123.71M$ 140.52M$ 157.71M
Cash Flow-
Free Cash Flow$ -33.83M$ -25.21M-$ -17.77M$ -26.29M
Operating Cash Flow$ -33.83M$ -25.14M$ -22.97M$ -17.77M$ -26.29M
Investing Cash Flow$ -219.29M$ 18.56M$ 16.23M$ -86.45M$ 12.23M
Financing Cash Flow$ 276.54M$ 24.83M$ 297.00K$ 432.00K$ 107.98M
Currency in USD

Vera Therapeutics Earnings and Revenue History

Vera Therapeutics Debt to Assets

Vera Therapeutics Cash Flow

Vera Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis